<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03148470</url>
  </required_header>
  <id_info>
    <org_study_id>SNF325130_156937_4</org_study_id>
    <nct_id>NCT03148470</nct_id>
  </id_info>
  <brief_title>Impact of Theta Burst Stimulation Over the Left DLPFC on Language Switching</brief_title>
  <official_title>Impact of Theta Burst Stimulation Over the Left Dorsolateral Prefrontal Cortex on Language Switching and Cognitive Flexibility</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jean-Marie Annoni</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Fribourg</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate whether theta burst stimulation (TBS) over the
      left dorsolateral prefrontal cortex (DLPFC) influences language switching and cognitive
      flexibility. The experimental paradigm will assess the impact of inhibitory and excitatory
      prefrontal stimulation by TBS versus sham-TBS over the DLPFC in healthy bilinguals.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background:

      Clinical observations and neuroimaging studies seem to confirm the role of executive
      functions and frontal structures in language processing in bilingual subjects.

      Repetitive transcranial magnetic stimulation, such as for example theta burst stimulation
      (TBS), is increasingly being used as a valuable tool for neuroscientists investigating the
      underlying mechanisms of cognitive functions. Case studies have shown a change in language
      switching after bilingual patients received repetitive magnetic stimulation to the left
      DLPFC. However, there is no study investigating the effect of TBS applied to the DLPFC on
      language switching in healthy participants.

      Procedure:

      A planned total of 40 unbalanced bilingual participants will be included. Half of the
      participants will receive inhibitory theta burst stimulation (continuous TBS), the other half
      excitatory theta burst stimulation (intermittent TBS). After TBS, different language and
      nonverbal tasks will be performed while an EEG is measured. Before being stimulated, each
      subject will conduct the same tasks with a sham-TBS as a baseline measure.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 2016</start_date>
  <completion_date type="Actual">July 2019</completion_date>
  <primary_completion_date type="Actual">July 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>RTs for Picture Naming With the Factors Language (L1, L2) and Block (Switching, Non-Switching)</measure>
    <time_frame>Within 30 minutes after intervention</time_frame>
    <description>Picture naming with the factors Language (L1, L2) and Block (Switching, Non-Switching): Speech onset times (msec) L1 refers to the mother tongue. L2 refers to the late acquired (&gt; age 7) second language. Switching Block refers to a language switching block with picture naming alternated between the mother tongue and the second language.
Non-Switching Block refers to a block of picture naming either only in the mother or only in the second language.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Nonverbal Switching</measure>
    <time_frame>Within 30 minutes after intervention</time_frame>
    <description>Nonverbal Switching: response times</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">41</enrollment>
  <condition>Languages</condition>
  <arm_group>
    <arm_group_label>intermittent theta burst stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>intermittent theta burst stimulation (iTBS) + Sham iTBS</description>
  </arm_group>
  <arm_group>
    <arm_group_label>continuous theta burst stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>continuous theta burst stimulation (cTBS) + Sham cTBS</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham iTBS</intervention_name>
    <description>Placebo stimulation for the iTBS group</description>
    <arm_group_label>intermittent theta burst stimulation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham cTBS</intervention_name>
    <description>Placebo stimulation for the cTBS group</description>
    <arm_group_label>continuous theta burst stimulation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>intermittent theta burst stimulation (iTBS)</intervention_name>
    <description>Excitatory theta burst stimulation</description>
    <arm_group_label>intermittent theta burst stimulation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>continuous theta burst stimulation (cTBS)</intervention_name>
    <description>inhibitory theta burst stimulation</description>
    <arm_group_label>continuous theta burst stimulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  L1 (Swiss)German, knowledge of English as a foreign language

          -  18-45 years of age

          -  right-handedness

        Exclusion Criteria:

          -  epilepsy / family history of epilepsy

          -  brain surgery, traumatic brain injuries

          -  cardiac pacemaker, metallic objects in the head

          -  history of neurological diseases or severe psychiatric disorders

          -  drug use (alcohol, psychoactive medication)

          -  strong headache

          -  pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Marie Annoni, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Fribourg</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Laboratory for Cognitive and Neurological Sciences</name>
      <address>
        <city>Fribourg</city>
        <zip>1700</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <reference>
    <citation>Holtzheimer P, Fawaz W, Wilson C, Avery D. Repetitive transcranial magnetic stimulation may induce language switching in bilingual patients. Brain Lang. 2005 Sep;94(3):274-7.</citation>
    <PMID>16098377</PMID>
  </reference>
  <reference>
    <citation>Lefaucheur JP, André-Obadia N, Antal A, Ayache SS, Baeken C, Benninger DH, Cantello RM, Cincotta M, de Carvalho M, De Ridder D, Devanne H, Di Lazzaro V, Filipović SR, Hummel FC, Jääskeläinen SK, Kimiskidis VK, Koch G, Langguth B, Nyffeler T, Oliviero A, Padberg F, Poulet E, Rossi S, Rossini PM, Rothwell JC, Schönfeldt-Lecuona C, Siebner HR, Slotema CW, Stagg CJ, Valls-Sole J, Ziemann U, Paulus W, Garcia-Larrea L. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS). Clin Neurophysiol. 2014 Nov;125(11):2150-2206. doi: 10.1016/j.clinph.2014.05.021. Epub 2014 Jun 5. Review.</citation>
    <PMID>25034472</PMID>
  </reference>
  <reference>
    <citation>Nardone R, De Blasi P, Bergmann J, Caleri F, Tezzon F, Ladurner G, Golaszewski S, Trinka E. Theta burst stimulation of dorsolateral prefrontal cortex modulates pathological language switching: A case report. Neurosci Lett. 2011 Jan 10;487(3):378-82. doi: 10.1016/j.neulet.2010.10.060. Epub 2010 Oct 29.</citation>
    <PMID>21036201</PMID>
  </reference>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>May 1, 2017</study_first_submitted>
  <study_first_submitted_qc>May 8, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 11, 2017</study_first_posted>
  <results_first_submitted>October 7, 2019</results_first_submitted>
  <results_first_submitted_qc>March 27, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">April 10, 2020</results_first_posted>
  <last_update_submitted>April 11, 2020</last_update_submitted>
  <last_update_submitted_qc>April 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Fribourg</investigator_affiliation>
    <investigator_full_name>Jean-Marie Annoni</investigator_full_name>
    <investigator_title>Prof. Dr. med.</investigator_title>
  </responsible_party>
  <keyword>theta burst stimulation</keyword>
  <keyword>Language switching</keyword>
  <keyword>dorsolateral prefrontal cortex</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>June 6, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/70/NCT03148470/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>iTBS Group</title>
          <description>intermittent theta burst stimulation (iTBS) + Sham iTBS
Sham iTBS: Placebo stimulation (3 Min)
Tasks (30 Min)
Pause (10Min)
iTBS: Excitatory stimulation (3Min)
Tasks (30Min)</description>
        </group>
        <group group_id="P2">
          <title>cTBS Group</title>
          <description>continuous theta burst stimulation (cTBS) + Sham cTBS
Sham cTBS: Placebo stimulation (40Sec)
Tasks (30min)
Pause (10Min)
cTBS: inhibitory stimulation (40 Sec)
Tasks (30Min)</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="21">21 Participants completed the Tasks following Sham-stimulation</participants>
                <participants group_id="P2" count="20">20 Participants completed the Tasks following Sham-stimulation</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="20">20 Participants completed the Tasks following iTBS-stimulation</participants>
                <participants group_id="P2" count="20">20 Participants completed the Tasks following cTBS-stimulation</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Intermittent Theta Burst Stimulation</title>
          <description>intermittent theta burst stimulation (iTBS) + Sham iTBS
Sham iTBS: Placebo stimulation
intermittent theta burst stimulation (iTBS): Excitatory rTMS</description>
        </group>
        <group group_id="B2">
          <title>Continuous Theta Burst Stimulation</title>
          <description>continuous theta burst stimulation (cTBS) + Sham cTBS
Sham cTBS: Placebo stimulation
continuous theta burst stimulation (cTBS): inhibitory rTMS</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="21"/>
            <count group_id="B2" value="20"/>
            <count group_id="B3" value="41"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="21"/>
                    <count group_id="B2" value="20"/>
                    <count group_id="B3" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="22.1" spread="2.7"/>
                    <measurement group_id="B2" value="22.8" spread="5.36"/>
                    <measurement group_id="B3" value="22.4" spread="4.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="21"/>
                    <count group_id="B2" value="20"/>
                    <count group_id="B3" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="31"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Switzerland</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="21"/>
                    <count group_id="B2" value="20"/>
                    <count group_id="B3" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>RTs for Picture Naming With the Factors Language (L1, L2) and Block (Switching, Non-Switching)</title>
        <description>Picture naming with the factors Language (L1, L2) and Block (Switching, Non-Switching): Speech onset times (msec) L1 refers to the mother tongue. L2 refers to the late acquired (&gt; age 7) second language. Switching Block refers to a language switching block with picture naming alternated between the mother tongue and the second language.
Non-Switching Block refers to a block of picture naming either only in the mother or only in the second language.</description>
        <time_frame>Within 30 minutes after intervention</time_frame>
        <population>As a primary outcome we compared RTs following iTBS vs cTBS. Sham-TBS is only used to have a baseline control between the two groups</population>
        <group_list>
          <group group_id="O1">
            <title>RTs for PN After Intermittent Theta Burst Stimulation</title>
            <description>intermittent theta burst stimulation (iTBS) - across switching and non-switching blocks and across L1 and L2.</description>
          </group>
          <group group_id="O2">
            <title>RTs for PN After Continuous Theta Burst Stimulation</title>
            <description>continuous theta burst stimulation (cTBS) - across switching and non-switching blocks and across L1 and L2.</description>
          </group>
          <group group_id="O3">
            <title>RTs for Picture Naming in L1</title>
            <description>Voice onset times for Picture Naming in L1 - across switching and non-switching blocks and across iTBS and cTBS.</description>
          </group>
          <group group_id="O4">
            <title>RTs for Picture Naming in L2</title>
            <description>Voice onset times for Picture Naming in L2 - across switching and non-switching blocks and across iTBS and cTBS.</description>
          </group>
          <group group_id="O5">
            <title>RTs for Picture Naming in the Non-switching Blocks</title>
            <description>Voice onset times for Picture Naming in the non-switching blocks - across L1 and L2 and across iTBS and cTBS.</description>
          </group>
          <group group_id="O6">
            <title>RTs for Picture Naming in the Switching Blocks</title>
            <description>Voice onset times for Picture Naming in the switching blocks - across L1 and L2 and across iTBS and cTBS.</description>
          </group>
        </group_list>
        <measure>
          <title>RTs for Picture Naming With the Factors Language (L1, L2) and Block (Switching, Non-Switching)</title>
          <description>Picture naming with the factors Language (L1, L2) and Block (Switching, Non-Switching): Speech onset times (msec) L1 refers to the mother tongue. L2 refers to the late acquired (&gt; age 7) second language. Switching Block refers to a language switching block with picture naming alternated between the mother tongue and the second language.
Non-Switching Block refers to a block of picture naming either only in the mother or only in the second language.</description>
          <population>As a primary outcome we compared RTs following iTBS vs cTBS. Sham-TBS is only used to have a baseline control between the two groups</population>
          <units>Milliseconds</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="40"/>
                <count group_id="O4" value="40"/>
                <count group_id="O5" value="40"/>
                <count group_id="O6" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1103.32" spread="126"/>
                    <measurement group_id="O2" value="1107.26" spread="131"/>
                    <measurement group_id="O3" value="1098.82" spread="405"/>
                    <measurement group_id="O4" value="1158.91" spread="432"/>
                    <measurement group_id="O5" value="1081.14" spread="414"/>
                    <measurement group_id="O6" value="1175.24" spread="420"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
              <group_id>O5</group_id>
              <group_id>O6</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.932</p_value>
            <p_value_desc>This p-value refers to the effect of stimulation (cTBS vs iTBS).</p_value_desc>
            <method>Mixed Models Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Nonverbal Switching</title>
        <description>Nonverbal Switching: response times</description>
        <time_frame>Within 30 minutes after intervention</time_frame>
        <population>Data are compared between iTBS and cTBS Sham-TBS is only used to have a baseline control between the two groups</population>
        <group_list>
          <group group_id="O1">
            <title>Intermittent Theta Burst Stimulation</title>
            <description>intermittent theta burst stimulation (iTBS)</description>
          </group>
          <group group_id="O2">
            <title>Continuous Theta Burst Stimulation</title>
            <description>continuous theta burst stimulation (cTBS)</description>
          </group>
        </group_list>
        <measure>
          <title>Nonverbal Switching</title>
          <description>Nonverbal Switching: response times</description>
          <population>Data are compared between iTBS and cTBS Sham-TBS is only used to have a baseline control between the two groups</population>
          <units>Milliseconds</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="772.07" spread="159.28"/>
                    <measurement group_id="O2" value="739.32" spread="137.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.642</p_value>
            <method>Mixed Models Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>3 hours</time_frame>
      <group_list>
        <group group_id="E1">
          <title>cTBS</title>
          <description>continuous theta burst stimulation (cTBS)</description>
        </group>
        <group group_id="E2">
          <title>iTBS</title>
          <description>intermittent theta burst stimulation (iTBS)</description>
        </group>
        <group group_id="E3">
          <title>Sham iTBS</title>
          <description>Placebo (baseline) stimulation for iTBS group</description>
        </group>
        <group group_id="E4">
          <title>Sham cTBS</title>
          <description>Placebo (baseline) stimulation for cTBS group</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="20"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="21"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="21"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Prof. Dr. Jean-Marie Annoni</name_or_title>
      <organization>University of Fribourg</organization>
      <phone>++4126 306 3802</phone>
      <email>jean-marie.annoni@unifr.ch</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

